COMMUNIQUÉS West-GlobeNewswire

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)
01/08/2025
Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in nAMD, the leading cause of vision loss in people over the age of 60 With two refills per year, Susvimo maintained [...]
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures
01/08/2025
CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient [...]
Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors
01/08/2025
BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other [...]
Emission obligataire additionnelle de 100 M€ dans le cadre de l’emprunt obligataire venant à maturité le 27 juin 2030, portant le montant total à 500 M€
01/08/2025
Communiqué de presse Clariane place avec succès une émission obligataire additionnelle de 100 millions d’euros dans le cadre de l’emprunt obligataire venant à maturité le 27 juin 2030, portant le montant total à 500 [...]
Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m
01/08/2025
Press release August 1 st , 2025 Clariane has successfully completed a tap issue in the amount of 100 million euros of its notes due June 27, 2030, bringing its total amount to 500 million euros Paris, 1 st August 2025 [...]
Regeneron Reports Second Quarter 2025 Financial and Operating Results
01/08/2025
Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter 2024 Dupixent ® global net sales (recorded by Sanofi) increased 22% to $4.34 billion EYLEA HD ® U.S. net sales increased 29% to $393 [...]
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
01/08/2025
PRINCETON, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2025 financial results on Friday, [...]
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
01/08/2025
Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL-2 superkine by [...]
BioXcel Therapeutics Announces Last Patient Last Visit in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
01/08/2025
Vast majority of patients dosed completed the full 12-week study Data from more than 2,200 agitation episodes collected Topline data readout anticipated this month NEW HAVEN, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) -- [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
01/08/2025
MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following [...]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/08/2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
01/08/2025
Aptose to hold a reconvened shareholder meeting on August 22, 2025 at 10:00 a.m. (Eastern Time) to vote on appointment of new auditor SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“ [...]
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
01/08/2025
MHRA indicated ART12.11 may be a candidate for accelerated development via the Innovative Licensing and Access Pathway SOLANA BEACH, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (“Artelo” or the “ [...]
FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES
01/08/2025
WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“ FOXO ” or the “ Company ”) today announced that its critical access designated rural hospital, Big South Fork [...]
Orchestra BioMed Announces Pricing of $40 Million Public Offering
01/08/2025
NEW HOPE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement
01/08/2025
LANGHORNE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Legend Senior Living Expands Management Team, Naming Brian Donnelly as Director of Dining Experience
01/08/2025
WICHITA, Kan., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider which operates over seventy residences in six states, has expanded its management team by adding [...]
Ascentage Pharma to Participate in Evercore China Biotech Summit
01/08/2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global biopharmaceutical company dedicated [...]

Pages